Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
AdaptHealth (AHCO)
NASDAQ:AHCO
Holding AHCO?
Track your performance easily
AHCO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.37 - $11.90
Previous Close$10.5
Volume615.76K
Average Volume (3M)1.07M
Market Cap
$1.41B
Enterprise Value$3.65B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$2.23B
Price to Earnings (P/E)―
Beta1.52
Next Earnings
Nov 05, 2024EPS Estimate
$0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.17
Shares Outstanding134,469,847
10 Day Avg. Volume514,429
30 Day Avg. Volume1,070,392
Standard Deviation0.17
R-Squared0.12
Alpha0.00079
Financial Highlights & Ratios
Price to Book (P/B)0.95
Price to Sales (P/S)0.43
Price to Cash Flow (P/CF)1.80
P/FCF Ratio2.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue44.91
Enterprise Value/Gross Profit7.61
Enterprise Value/Ebitda-17.43
Forecast
1Y Price Target
$12.75Price Target Upside21.43% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
AdaptHealth News
PremiumCompany Announcements
AdaptHealth Announces New CTO Employment Agreement
PremiumCompany Announcements
AdaptHealth Strengthens Leadership with New Board Appointment
PremiumCompany Announcements
AdaptHealth Clarifies Expiration Date for Private Warrants
PremiumCompany Announcements
AdaptHealth’s Strategic Refinancing for Growth and Efficiency
PremiumCompany Announcements
AdaptHealth Welcomes New COO, Aims for Operational Excellence
Bulls Say, Bears Say
Bulls Say
Financial PerformanceFree cash flow of $166.7M exceeded the estimate, and FCF guidance was raised at the low-end to $160-$180M.
Market PositionSleep is holding strong, Respiratory is taking share and moved to #1 market position, and Diabetes is a bit delayed on recovery but not materially so and offset fully by the other categories.
Strategic InitiativesAHCO continues to make strides to simplify the organization with the sale of many non-core HME businesses, which should meaningfully reduce management distractions and enhance focus on more important strategic initiatives.
Bears Say
Financial PerformanceDiabetes revenues declined approximately 10% year-over-year in the quarter, with results more unfavorable than expected.
Quarterly OutlookThe implied apples to apples 3Q outlook is approximately 3% below consensus on revenues and 4% on EBITDA, with margins roughly 30 basis points below expectations.
Revenue Guidance2024 revenue guidance was trimmed at the high-end while the mid-point of the EBITDA outlook was maintained on a $10 million narrowing of the range at both the high and low ends.
---
Ownership Overview
14.32% Insiders
19.03% Mutual Funds
5.76% Other Institutional Investors
39.92% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AHCO FAQ
What was AdaptHealth’s price range in the past 12 months?
AdaptHealth lowest stock price was $6.37 and its highest was $11.90 in the past 12 months.
What is AdaptHealth’s market cap?
Currently, no data Available
When is AdaptHealth’s upcoming earnings report date?
AdaptHealth’s upcoming earnings report date is Nov 05, 2024 which is in 3 days.
How were AdaptHealth’s earnings last quarter?
AdaptHealth released its earnings results on Aug 06, 2024. The company reported $0.216 earnings per share for the quarter, beating the consensus estimate of $0.192 by $0.024.
Is AdaptHealth overvalued?
According to Wall Street analysts AdaptHealth’s price is currently Undervalued.
Does AdaptHealth pay dividends?
AdaptHealth does not currently pay dividends.
What is AdaptHealth’s EPS estimate?
AdaptHealth’s EPS estimate is $0.19.
How many shares outstanding does AdaptHealth have?
AdaptHealth has 134,469,850 shares outstanding.
What happened to AdaptHealth’s price movement after its last earnings report?
AdaptHealth reported an EPS of $0.216 in its last earnings report, beating expectations of $0.192. Following the earnings report the stock price went down -21.057%.
Which hedge fund is a major shareholder of AdaptHealth?
Among the largest hedge funds holding AdaptHealth’s share is Deerfield Management Company, LP. It holds AdaptHealth’s shares valued at 133M.
---
AdaptHealth Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.75 (21.43% Upside)
$12.75 (21.43% Upside)
Blogger Sentiment
Bullish
AHCO Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 1.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.8M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
46.64%
12-Months-Change
Fundamentals
Return on Equity
-37.80%
Trailing 12-Months
Asset Growth
-13.30%
Trailing 12-Months
Company Description
AdaptHealth
AdaptHealth Corp. provides medical products for both rental and sale. It focuses on respiratory and/or mobility equipment, including CPAP sleep equipment, oxygen equipment, wheelchairs, walkers, and hospital beds. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.
---
AHCO Earnings Call
Q2 2024
0:00 / 0:00
---
AHCO Stock 12 Month Forecast
Average Price Target
$12.75
▲(21.43% Upside)
Technical Analysis
Best Analysts Covering AHCO
1 Year
1 Year Success Rate
8/18 ratings generated profit
1 Year Average Return
-14.71%
reiterated a buy rating 3 months ago
Copying Richard Close's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of -14.71% per trade.
---